Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q1 2023 to Q2 2023
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 1
- Est. +$93.8K
- Added
- 22
- Est. +$6.19M
- Reduced
- 41
- Est. −$15.9M
- Sold out
- 15
- Est. −$11.1M
Portfolio value went from $194.0M to $175.3M (−$18.7M (−9.6%)); positions from 79 to 65 (−14).
All Q2 2023 holdingsAll Q1 2023 holdings
In the shares, value and % of portfolio columns, the top figure is Q2 2023 and the gray one below is Q1 2023. For stocks that split between the two quarters, Q1 2023 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| NKTXNkarta, Inc. | ReducedHistory | 10,36710,475 | −108−1.0% | $22.7K$37.2K | −$236.53 | <0.1%<0.1% | −0.01 |
| PSTXPoseida Therapeutics, Inc. | AddedHistory | 26,61915,040 | +11,579+77.0% | $46.9K$46.3K | +$20.4K | <0.1%<0.1% | 0.00 |
| GERNGeron Corp | ReducedHistory | 14,89127,582 | −12,691−46.0% | $47.8K$59.9K | −$40.7K | <0.1%<0.1% | 0.00 |
| LONALeonaBio, Inc. | ReducedHistory | 20,81021,625 | −815−3.8% | $61.4K$54.1K | −$2.40K | <0.1%<0.1% | +0.01 |
| KRONKronos Bio, Inc. | ReducedHistory | 39,06839,295 | −227−0.6% | $67.2K$57.4K | −$390.44 | <0.1%<0.1% | +0.01 |
| Achilles Therapeutics PLC00449L102 | Reduced– | 74,76975,625 | −856−1.1% | $70.7K$72.4K | −$809.11 | <0.1%<0.1% | 0.00 |
| CTMXCytomX Therapeutics, Inc. | AddedHistory | 49,59626,412 | +23,184+87.8% | $85.3K$39.9K | +$39.9K | <0.1%<0.1% | +0.03 |
| FUSNFusion Pharmaceuticals Inc. | NewHistory | 20,0750 | +20,075 | $93.8K$0 | +$93.8K | 0.1%0.0% | +0.05 |
| ANNXAnnexon, Inc. | AddedHistory | 26,79015,251 | +11,539+75.7% | $94.3K$58.7K | +$40.6K | 0.1%<0.1% | +0.02 |
| JSPRJasper Therapeutics, Inc. | AddedHistory | 69,36730,290 | +39,077+129.0% | $95.0K$54.8K | +$53.5K | 0.1%<0.1% | +0.03 |
| MREOMereo BioPharma Group plc | ReducedHistory | 82,74983,700 | −951−1.1% | $109.2K$59.2K | −$1.26K | 0.1%<0.1% | +0.03 |
| MDTMedtronic plc | ReducedHistory | 2,4313,284 | −853−26.0% | $214.2K$264.7K | −$75.2K | 0.1%0.1% | −0.01 |
| INCYIncyte Corp | AddedHistory | 3,5333,525 | +8+0.2% | $219.9K$254.8K | +$498 | 0.1%0.1% | −0.01 |
| TMOThermo Fisher Scientific Inc. | ReducedHistory | 427475 | −48−10.1% | $223.1K$274.0K | −$25.1K | 0.1%0.1% | −0.01 |
| REGNRegeneron Pharmaceuticals, Inc. | ReducedHistory | 341357 | −16−4.5% | $245.0K$293.3K | −$11.5K | 0.1%0.2% | −0.01 |
| iShares Inc46434G863 | Added– | 8,3008,294 | +6+0.1% | $262.5K$261.1K | +$189.79 | 0.1%0.1% | +0.02 |
| PFEPfizer Inc | AddedHistory | 7,7356,074 | +1,661+27.3% | $283.8K$247.9K | +$60.9K | 0.2%0.1% | +0.03 |
| SPDR Series Trust78468R622 | Reduced– | 3,1534,315 | −1,162−26.9% | $290.2K$400.5K | −$106.9K | 0.2%0.2% | −0.04 |
| UNHUnitedHealth Group Inc | AddedHistory | 630536 | +94+17.5% | $303.9K$254.1K | +$45.3K | 0.2%0.1% | +0.04 |
| iShares Tr46434V647 | Added– | 14,82814,744 | +84+0.6% | $340.6K$338.1K | +$1.93K | 0.2%0.2% | +0.02 |
| Vanguard Emerging Markets Government Bond ETF921946885 | Added– | 6,0646,011 | +53+0.9% | $377.6K$374.6K | +$3.30K | 0.2%0.2% | +0.02 |
| Tidal ETF Tr886364603 | Reduced– | 22,18529,239 | −7,054−24.1% | $426.6K$571.9K | −$135.6K | 0.2%0.3% | −0.05 |
| DEDeere & Co | AddedHistory | 1,0981,090 | +8+0.7% | $444.9K$450.2K | +$3.24K | 0.3%0.2% | +0.02 |
| Schwab U.S. Small-Cap ETF808524607 | Added– | 10,30810,271 | +37+0.4% | $451.5K$430.7K | +$1.62K | 0.3%0.2% | +0.04 |
| Invesco Exch Traded FD Tr II46138E263 | Unchanged– | 8,9648,964 | 00.0% | $460.8K$446.9K | $0 | 0.3%0.2% | +0.03 |
| ProShares Tr74347R842 | Reduced– | 14,49315,092 | −599−4.0% | $498.6K$480.2K | −$20.6K | 0.3%0.2% | +0.04 |
| JPMJPMorgan Chase & Co | AddedHistory | 3,4503,414 | +36+1.1% | $501.8K$444.9K | +$5.24K | 0.3%0.2% | +0.06 |
| iShares Tr464287432 | Reduced– | 5,9837,803 | −1,820−23.3% | $615.9K$830.2K | −$187.4K | 0.4%0.4% | −0.08 |
| Invesco Exch TRD SLF Idx FD46138J460 | Reduced– | 43,22250,726 | −7,504−14.8% | $700.2K$836.5K | −$121.6K | 0.4%0.4% | −0.03 |
| NVDANVIDIA Corp | ReducedHistory | 1,7372,442 | −705−28.9% | $735.0K$678.4K | −$298.3K | 0.4%0.3% | +0.07 |
| iShares MSCI USA Min Vol Factor ETF46429B697 | Reduced– | 10,37011,113 | −743−6.7% | $770.7K$808.3K | −$55.2K | 0.4%0.4% | +0.02 |
| State Street Real Estate Select Sector SPDR ETF81369Y860 | Added– | 27,53727,265 | +272+1.0% | $1.04M$1.02M | +$10.3K | 0.6%0.5% | +0.07 |
| iShares Tr46429B655 | Added– | 20,45120,170 | +281+1.4% | $1.04M$1.02M | +$14.3K | 0.6%0.5% | +0.07 |
| DJPBarclays Bank PLC | ReducedHistory | 42,44345,431 | −2,988−6.6% | $1.30M$1.44M | −$91.3K | 0.7%0.7% | 0.00 |
| iShares Trust iShares 0-1 Year Treasury Bond ETF464288679 | Added– | 12,08012,012 | +68+0.6% | $1.33M$1.33M | +$7.51K | 0.8%0.7% | +0.08 |
| Vanguard Total International Bond ETF92203J407 | Reduced– | 30,84534,834 | −3,989−11.5% | $1.51M$1.70M | −$195.0K | 0.9%0.9% | −0.02 |
| WisdomTree Tr97717W562 | Reduced– | 33,69742,609 | −8,912−20.9% | $1.51M$1.84M | −$399.4K | 0.9%0.9% | −0.09 |
| Vanguard Morningstar Value ETF922908744 | Reduced– | 10,93713,308 | −2,371−17.8% | $1.55M$1.84M | −$336.9K | 0.9%0.9% | −0.06 |
| Invesco Exchange Traded FD T46137V837 | Reduced– | 19,37536,919 | −17,544−47.5% | $1.57M$2.80M | −$1.42M | 0.9%1.4% | −0.55 |
| iShares Tr464288588 | Reduced– | 18,84019,393 | −553−2.9% | $1.76M$1.84M | −$51.6K | 1.0%0.9% | +0.06 |
| iShares Inc46434G509 | Reduced– | 73,37091,256 | −17,886−19.6% | $1.80M$2.19M | −$438.9K | 1.0%1.1% | −0.10 |
| SPDR Series Trust78468R200 | Added– | 60,74960,231 | +518+0.9% | $1.86M$1.83M | +$15.9K | 1.1%0.9% | +0.12 |
| iShares Tr46429B747 | Added– | 21,41621,382 | +34+0.2% | $2.09M$2.12M | +$3.32K | 1.2%1.1% | +0.10 |
| iShares Tr464288661 | Reduced– | 18,68219,114 | −432−2.3% | $2.15M$2.25M | −$49.8K | 1.2%1.2% | +0.07 |
| iShares Tips Bond ETF464287176 | Reduced– | 20,31621,368 | −1,052−4.9% | $2.19M$2.36M | −$113.2K | 1.2%1.2% | +0.03 |
| Invesco Exch Traded FD Tr II46138G508 | Reduced– | 106,171117,340 | −11,169−9.5% | $2.23M$2.44M | −$235.0K | 1.3%1.3% | +0.02 |
| Vanguard Morningstar Small-Cap ETF922908751 | Added– | 11,36111,316 | +45+0.4% | $2.26M$2.15M | +$8.95K | 1.3%1.1% | +0.18 |
| iShares Tr464287440 | Reduced– | 24,29325,576 | −1,283−5.0% | $2.35M$2.54M | −$123.9K | 1.3%1.3% | +0.03 |
| iShares Tr464288281 | Reduced– | 28,76433,662 | −4,898−14.6% | $2.49M$2.90M | −$423.9K | 1.4%1.5% | −0.08 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 6,4139,747 | −3,334−34.2% | $2.86M$4.01M | −$1.49M | 1.6%2.1% | −0.44 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Reduced– | 26,94628,343 | −1,397−4.9% | $2.91M$3.11M | −$151.1K | 1.7%1.6% | +0.06 |
| Vanguard Intl Equity Index F922042676 | Reduced– | 78,80791,580 | −12,773−13.9% | $3.17M$3.72M | −$513.4K | 1.8%1.9% | −0.11 |
| Vanguard Real Estate ETF922908553 | Reduced– | 55,40257,231 | −1,829−3.2% | $4.63M$4.75M | −$152.8K | 2.6%2.5% | +0.19 |
| Vanguard World FD921910709 | Reduced– | 57,21559,596 | −2,381−4.0% | $4.98M$5.40M | −$207.3K | 2.8%2.8% | +0.06 |
| First Tr Exchange-Traded FD33738D101 | Reduced– | 192,841249,706 | −56,865−22.8% | $5.21M$6.65M | −$1.54M | 3.0%3.4% | −0.46 |
| SPDR Series Trust78464A490 | Reduced– | 129,937136,698 | −6,761−4.9% | $5.43M$5.91M | −$282.3K | 3.1%3.0% | +0.05 |
| iShares Core High Dividend ETF46429B663 | Reduced– | 56,98270,573 | −13,591−19.3% | $5.74M$7.17M | −$1.37M | 3.3%3.7% | −0.42 |
| DBX ETF Tr233051200 | Reduced– | 172,761217,242 | −44,481−20.5% | $6.11M$7.65M | −$1.57M | 3.5%3.9% | −0.46 |
| iShares Tr464288372 | Reduced– | 151,016172,832 | −21,816−12.6% | $7.09M$8.24M | −$1.02M | 4.0%4.3% | −0.21 |
| SPYSPDR S&P 500 ETF Trust | AddedHistory | 19,76119,688 | +73+0.4% | $8.76M$8.06M | +$32.4K | 5.0%4.2% | +0.84 |
| PIMCO ETF Tr72201R304 | Reduced– | 171,251182,082 | −10,831−5.9% | $10.3M$11.2M | −$650.3K | 5.9%5.8% | +0.08 |
| Vanguard Ftse Developed Markets ETF921943858 | Added– | 269,566267,051 | +2,515+0.9% | $12.4M$12.1M | +$116.1K | 7.1%6.2% | +0.88 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Reduced– | 96,278103,181 | −6,903−6.7% | $13.9M$14.3M | −$995.8K | 7.9%7.4% | +0.53 |
| Vanguard Ftse Emerging Markets ETF922042858 | Reduced– | 367,931392,854 | −24,923−6.3% | $15.0M$15.9M | −$1.01M | 8.5%8.2% | +0.36 |
| iShares Tr46435G516 | Added– | 351,518273,342 | +78,176+28.6% | $25.6M$19.6M | +$5.70M | 14.6%10.1% | +4.50 |
| Nushares ETF Tr67092P300 | Sold out– | 0187,045 | −187,045−100.0% | $0$6.37M | −$6.37M | 0.0%3.3% | −3.29 |
| IAUiShares Gold Trust | Sold outHistory | 046,743 | −46,743−100.0% | $0$1.75M | −$1.75M | 0.0%0.9% | −0.90 |
| DBAInvesco DB Agriculture Fund | Sold outHistory | 040,111 | −40,111−100.0% | $0$819.5K | −$819.5K | 0.0%0.4% | −0.42 |
| State Street Energy Select Sector SPDR ETF81369Y506 | Sold out– | 06,120 | −6,120−100.0% | $0$506.9K | −$506.9K | 0.0%0.3% | −0.26 |
| DBCInvesco DB Commodity Index Tracking Fund | Sold outHistory | 013,343 | −13,343−100.0% | $0$316.8K | −$316.8K | 0.0%0.2% | −0.16 |
| iShares Tr464287234 | Sold out– | 07,748 | −7,748−100.0% | $0$305.7K | −$305.7K | 0.0%0.2% | −0.16 |
| ABTAbbott Laboratories | Sold outHistory | 03,009 | −3,009−100.0% | $0$304.7K | −$304.7K | 0.0%0.2% | −0.16 |
| iShares Tr464288513 | Sold out– | 02,948 | −2,948−100.0% | $0$222.7K | −$222.7K | 0.0%0.1% | −0.11 |
| PHGKoninklijke Philips NV | Sold outHistory | 010,000 | −10,000−100.0% | $0$183.5K | −$183.5K | 0.0%0.1% | −0.09 |
| ORTXOrchard Therapeutics plc | Sold outHistory | 014,654 | −14,654−100.0% | $0$78.7K | −$78.7K | 0.0%<0.1% | −0.04 |
| ALXOAlx Oncology Holdings Inc | Sold outHistory | 013,037 | −13,037−100.0% | $0$58.9K | −$58.9K | 0.0%<0.1% | −0.03 |
| DMDesktop Metal, Inc. | Sold outHistory | 021,308 | −21,308−100.0% | $0$49.0K | −$49.0K | 0.0%<0.1% | −0.03 |
| EIGREiger BioPharmaceuticals, Inc. | Sold outHistory | 051,679 | −51,679−100.0% | $0$46.3K | −$46.3K | 0.0%<0.1% | −0.02 |
| SURFSurface Oncology, Inc. | Sold outHistory | 061,156 | −61,156−100.0% | $0$42.7K | −$42.7K | 0.0%<0.1% | −0.02 |
| CDAKCodiak BioSciences, Inc. | Sold outHistory | 0110,210 | −110,210−100.0% | $0$19.2K | −$19.2K | 0.0%<0.1% | −0.01 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.